Urinary albumin excretion - A predictor of risk of cardiovascular disease: A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men

American Journal of Hypertension

Volumn 9, Issue 8 I, 1996, Pages 770-778

  Ljungman, Susanne ^a   Wikstrand, John ^b,c   Hartford, Marianne ^a   Berglund, Göran ^a,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Cardiovascular disease; Epidemiology; Essential hypertension; Microalbuminuria; Prediction; Proteinuria

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIURETIC AGENT; HYDRALAZINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0029760174     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00102-1     Document Type: Article

References (47)

1. Bechgaard P: Arterial hypertension. A follow-up study of 1000 hypertonics. Acta Med Scand 1946;(suppl 172):3-358.
2. Kannel WB, Stampfer MJ, Castelli WP, et al: The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-1352.
3. Samuelsson O, Wilhelmsen L, Elmfeldt D, et al: Predictors of cardiovascular morbidity in treated hypertension: results from the Primary Preventive Trial in Göteborg, Sweden. J Hypertens 1985;3:167-176.
4. Bulpitt CJ, Beilin LJ, Clifton P, et al: Risk factors for death in treated hypertensive patients. Report from the DHSS Hypertension Care Computing Project. Lancet 1979;ii:134-137.
5. Lewin A, Blaufox MD, Castle H, et al: Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med 1985; 145:424-427.
6. Ruilope LM, Alcazar JM, Hernandez E, et al: Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens 1990;8:525-531.
7. Viberti GC, Hill RD, Jarrett RJ, et al: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-1432.
8. Parving HH, Oxenboll B, Svendsen PA, et al: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 1982;100:550-555.
9. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
10. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360.
11. Jarett RJ, Viberti GC, Argyropoulus A, et al: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1984;1:17-19.
12. Giaconi S, Levanti C, Fommei E, et al: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. AmJ Hypertens 1989; 2:259-261.
13. Opsahl JA, Abraham PA, Halstenson CE, et al: Correlation of office and ambulatory blood pressure measurements and urinary albumin and N-acetyl-β-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988;1:117S-120S.
14. Cerasola G, Cottone S, D'Ignoto G, et al: Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989;7(suppl 6): S332-S333.
15. Bigazzi R, Bianchi S, Campese VM, et al: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992;61:94-97.
16. Ljungman S, Wikstrand J, Hartford M, et al: Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension. Am J Hypertens 1993;6:554-563.
17. Agewall S, Persson B, Samuelsson O, et al, on behalf of The Risk Factor Intervention Study Group: Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993;11:461-469.
18. Mimran A, Ribstein J: Microalbuminuria in essential hypertension. Clin Exp Hypertens 1993;15:1061-1067.
19. Redon J, Liao Y, Lozano JV, et al: Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994;7:801-807.
20. Parving HH, Jensen HÆ, Mogensen CE, et al: Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974;i:1190-1192.
21. Bianchi S, Bigazzi R, Valtriani C, et al: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994;23:681-687.
22. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;ii:530-533.
23. Damsgaard EM, Fröland A, Jörgensen OD, et al: Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990;300:297-300.
24. Haffner SM, Stern MP, Kozlowski Gruber MK, et al: Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990;10:727-731.
25. Ljungman S, Aurell M, Hartford M, et al: Blood pressure and renal function. Acta Med Scand 1980;208:17-25.
26. Ljungman S: Renal function, sodium excretion and the renin-angiotensin-aldosterone system in relation to blood pressure. An epidemiological and physiological study. Acta Med Scand 1982;(suppl 663):1-68.
27. Hartford M, Wendelhag I, Berglund G, et al: Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988;259:2553-2557.
28. Leffler HH: Estimation of cholesterol in serum. Am J Clin Pathol 1959;31:310-313.
29. Ljungman S, Aurell M, Hartford M, et al: Blood pressure in relation to the renin-angiotensin-aldosterone system. Acta Med Scand 1982;211:351-360.
30. Hartford M, Wikstrand J, Wallentin I, et al: Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors. Clin Exp Hypertens 1983;5:1429-1451.
31. Ljungman S, Aurell M, Hartford M, et al: Sodium excretion and blood pressure. Hypertension 1981;3:318-326.
32. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966;15:45-52.
33. Hartford M, Wikstrand J, Wallentin I, et al: Non-invasive signs of cardiac involvement in essential hypertension. Eur Heart J 1982;3:75-87.
34. Berglund G, Ljungman S, Hartford M, et al: Total, renal and calf muscle resistance in relation to blood pressure. Implications for the development of essential hypertension. J Hypertens 1983;1(suppl 2):286-288.
35. Bradley JW: Distribution-Free Statistical Tests. Prentice-Hall, London, 1968, pp 68-86.
36. Merck C, Angervall L, Kindblom LG, et al: Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathological and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983;(suppl 282):1-40.
37. Breslow NE, Day NE: Statistical Methods in Cancer Research. Volume II. The Design and Analysis of Cohort Studies. IARC Scientific Publications, Lyon, France, 1987, pp 131-135.
38. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension II: results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-1152.
39. Beevers DG, Johnston J, Devine BL, et al: Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci 1978;55:333s-336s.
40. Wilhelmsen L, Wedel H, Tibblin G: Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-958.
41. Stamler J: Research related to risk factors. Circulation 1979;60:1575-1587.
42. Pedrinelli R, Giampietro O, Carmassi F, et al: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994;344:14-18.
43. Agewall S, Fagerberg B, Attwall S, et al, on behalf of the Risk Factor Intervention Study Group: Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. J Int Med 1995;237:195-203.
44. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
45. Damsgaard EM, Mogensen CE: Microalbuminuria in elderly hyperglycaemic patients and controls. Diabet Med 1986;3(5):430-435.
46. Jensen JS, Borch-Johnsen K, Jensen G, et al: Microalbuminuria reflects a generalized transvascular albumin leakage in clinically healthy subjects. Clin Sci 1995; 88:629-633.
47. Agewall S, Wikstrand J, Ljungman S, et al, on behalf of the Risk Factor Intervention Study Group: Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Am J Hypertens 1995;8:337-342.